Stada Group
Yen-Yu Lai currently serves as Manager Global Process Purchase-to-Pay at STADA, beginning in August 2023, where responsibilities include optimizing workflows and streamlining processes between external service providers and the procurement and accounting departments. Previously, Yen-Yu held the position of Einkauf-Controller at STADA AG from April 2011 to October 2017. Earlier experience includes roles such as Niederlassungsleitung Asien at ALBAT+WIRSAM Software AG, managing operations in Australia, New Zealand, and Japan from April 2006 to December 2008, Business Manager in SCM & Procurement at Medion AG from February 2004 to December 2005, and Project-Controllerin at Deutsche Bank AG from July 1997 to November 2002. Yen-Yu Lai earned a Diplom-Kauffrau in Wirtschaftswissenschaften from Universität des Saarlandes between 1993 and 1996.
This person is not in any teams
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.